MHRA-100754-PIP01-22-M01 (update)

Key Facts

Active Substance
Active Substance:
  • Live-attenuated La Reunion strain of chikungunya virus
Invented Name
Not yet available
PIP Number MHRA-100754-PIP01-22-M01 (update)
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Powder and solvent for suspension for injection
Therapeutic area
Therapeutic area:
  • Vaccines
Conditions / Indications
Conditions / Indications:
  • Prevention of chikungunya virus disease
Route(s) of administration
Route(s) of administration:
  • Intramuscular use
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
Yes
Compliance Check Decision Date
Compliance opinion date
17/06/2024
Compliance Check Procedure Number
Compliance procedure number
MHRA-100754-PIP01-22-M01-C1

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Live-attenuated La Reunion strain of chikungunya virus .pdf
Published Date 24/06/2024